Home > Annual Financials > GUFIC BIOSCIENCES

GUFIC BIOSCIENCES Financial Statement Analysis
[BOM: 509079|NSE : GUFICBIO]

The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -16.89 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹691 Cr₹779 Cr₹488 Cr₹379 Cr₹351 Cr
Expenses ₹556 Cr₹631 Cr₹404 Cr₹327 Cr₹305 Cr
Operating Profit (Excl OI) ₹135 Cr₹148 Cr₹84 Cr₹52 Cr₹46 Cr
Other Income ₹2.57 Cr₹3.10 Cr₹3.73 Cr₹5.79 Cr₹4.17 Cr
Interest ₹8.22 Cr₹5.37 Cr₹14 Cr₹14 Cr₹10 Cr
Depreciation ₹22 Cr₹19 Cr₹16 Cr₹14 Cr₹4.65 Cr
Profit Before Tax ₹107 Cr₹127 Cr₹58 Cr₹30 Cr₹35 Cr
Profit After Tax ₹80 Cr₹96 Cr₹44 Cr₹23 Cr₹22 Cr
Consolidated Net Profit ₹80 Cr₹96 Cr₹44 Cr₹23 Cr₹22 Cr
Earnings Per Share (Rs)₹8.22₹9.89₹4.56₹2.34₹2.82
PAT Margin (%)9.9511.308.535.806.09
ROE(%)25.8443.3129.2222.1733.89
ROCE(%)23.2347.2930.0521.0129.65
Total Debt/Equity(x)0.900.230.320.901.30

Key Financials

Market Cap : ₹ 2,840.0 Cr
Revenue (TTM) : ₹ 784.7 Cr
Net Profit(TTM) : ₹ 84.2 Cr
EPS (TTM) : ₹ 8.4
P/E (TTM) : 33.7

Industry Peers & Returns1W1M1Y
GUFIC BIOSCIENCES 0.4% -7.8% 52.5%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%


GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-11.36 %

5 Yr CAGR

18.46 %

Years Revenues % Change
Mar2023 ₹691 Cr
-11.36
Mar2022 ₹779 Cr
59.76
Mar2021 ₹488 Cr
28.74
Mar2020 ₹379 Cr
8.00
Mar2019 ₹351 Cr -


GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-9.04 %

5 Yr CAGR

30.81 %

Years Operating Profit % Change
Mar2023 ₹135 Cr
-9.04
Mar2022 ₹148 Cr
76.39
Mar2021 ₹84 Cr
61.03
Mar2020 ₹52 Cr
13.33
Mar2019 ₹46 Cr -

Operating Margins
Y-o-Y

2.63 %

5 Yr CAGR

10.44 %

Years Operating Margin% % Change
Mar2023 19.5%
2.63
Mar2022 19%
10.40
Mar2021 17.21%
25.07
Mar2020 13.76%
4.96
Mar2019 13.11% -

GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-16.84 %

5 Yr CAGR

38.06 %

Years Profit After Tax % Change
Mar2023 ₹80 Cr
-16.84
Mar2022 ₹96 Cr
116.68
Mar2021 ₹44 Cr
94.96
Mar2020 ₹23 Cr
3.40
Mar2019 ₹22 Cr -

PAT Margins
Y-o-Y

-11.95 %

5 Yr CAGR

13.06 %

Years PAT Margin(%) % Change
Mar2023 9.95 %
-11.95
Mar2022 11.3 %
32.47
Mar2021 8.53 %
47.07
Mar2020 5.8 %
-4.76
Mar2019 6.09 % -

GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-16.89 %

5 Yr CAGR

30.66 %

Years EPS % Change
Mar2023 ₹8.22
-16.89
Mar2022 ₹9.89
116.89
Mar2021 ₹4.56
94.87
Mar2020 ₹2.34
-17.02
Mar2019 ₹2.82 -

GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-50.88 %

5 Yr CAGR

-5.92 %

Years ROCE % Change
Mar2023 23.23%
-50.88
Mar2022 47.29%
57.37
Mar2021 30.05%
43.03
Mar2020 21.01%
-29.14
Mar2019 29.65% -

GUFIC BIOSCIENCES Share Price vs Sensex

Current Share Price : ₹283.2
Current MarketCap: ₹ 2,840.0 Cr
Updated EOD on :Mar 28,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
GUFIC BIOSCIENCES

0.4%

-7.8%

52.5%

SENSEX

-0.4%

-0.9%

25.8%

GUFIC BIOSCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 1.9% -4.4% 61.2%
S&P BSE SMALL CAP 1.8% -6.7% 58.8%
S&P BSE HEALTHCARE 1% -3.2% 60.6%
S&P BSE ALLCAP 0.8% -1.8% 40.5%
No NSE index found

You may also like the below Video Courses


FAQ about GUFIC BIOSCIENCES Financials


How the annual revenues of GUFIC BIOSCIENCES have changed ?

The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .

How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?

The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -16.89 % YoY .